This peptide specifically targets and inhibits the activity of p53, a well-known tumor suppressor protein, allowing for the selective elimination of senescent cells, which are implicated in aging and age-related diseases
FDA warning against unapproved GLP-1 drugs for weight loss The official website of FDA clearly states that unapproved versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs can be risky for patients
This may be due to a browser extension, network issues, or browser settings
Book your telehealth consultation today
An unopened, lyophilized GHK-Cu vial stored consistently in a freezer at -20C (or -4F) can typically last for 1-2 years
Food and Drug Administration warned compounders in 2019 not to use glutathione-L-reduced powder distributed by Letco Medical in Decatur, Alabama to compound sterile injectable drugs for patients